HomeInsightsPE

Krebs Biochemicals & Industries Ltd PE Ratio

Krebs Biochemicals & Industries Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

0.1 K

stocks traded

Last Updated time: 12 Oct 12:05 PM

Image

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO

PE

0

Last updated: 12 Oct 12:05 PM

Key Highlights

  • The P/E Ratio of Krebs Biochemicals & Industries Ltd is 0 as of 12 Oct 12:05 PM.
  • The P/E Ratio of Krebs Biochemicals & Industries Ltd changed from 0 on March 2019 to 0 on March 2024 . This represents a CAGR of 0.0% over 6 years. .
  • The Latest Trading Price of Krebs Biochemicals & Industries Ltd is ₹ 80.93 as of 11 Oct 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.2. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Krebs Biochemicals & Industries Ltd

No data available

Company Fundamentals for Krebs Biochemicals & Industries Ltd

No data available

Image

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO

PRICE

80.93

1.58 (1.99%)

stock direction

Last updated: 11 Oct 15:30

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Krebs Biochemicals & Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
11 Oct 202480.93
10 Oct 202479.35
09 Oct 202479.35
08 Oct 202477.8
07 Oct 202479.38
04 Oct 202481
03 Oct 202480
01 Oct 202480
30 Sep 202481.5
27 Sep 202481.5

SWOT Analysis Of Krebs Biochemicals & Industries Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Krebs Biochemicals & Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Krebs Biochemicals & Industries Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Krebs Biochemicals & Industries Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Krebs Biochemicals & Industries Ltd

No data available

* All values are in crore

Historical Revenue of Krebs Biochemicals & Industries Ltd

No data available

* All values are in crore

Historical EBITDA of Krebs Biochemicals & Industries Ltd

No data available

* All values are in crore

Historical Net Profit of Krebs Biochemicals & Industries Ltd

No data available

* All values are in crore

Historical Dividend Payout of Krebs Biochemicals & Industries Ltd

No data available

* All values are in %

About Krebs Biochemicals & Industries Ltd

  • Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry.
  • Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process.

Krebs Biochemicals & Industries Ltd News Hub

News

Krebs Biochemicals & Industries schedules AGM

Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of th...

Read more

09 Sep 202410:11

News

Krebs Biochemicals & Industries to announce Quarterly Result

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

22 Jul 202410:35

News

Krebs Biochemicals & Industries Ltd leads gainers in 'B' group

North Eastern Carrying Corporation Ltd, Capital Trust Ltd, Kilitch Drugs (India) Ltd and G...

Read more

19 Jul 202412:15

News

Krebs Biochemicals & Industries Ltd leads gainers in 'B' group

Remedium Lifecare Ltd, Mahanagar Telephone Nigam Ltd, Coastal Corporation Ltd and Quick He...

Read more

18 Jul 202412:15

News

Krebs Biochemicals & Industries Ltd leads gainers in 'B' group

Shreyans Industries Ltd, Alphageo (India) Ltd, Coral India Finance & Housing Ltd and IVP L...

Read more

08 Jul 202412:16

News

Krebs Biochemicals & Industries announces board meeting date

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

08 May 202412:55

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Krebs Biochemicals & Industries Ltd

What is the current PE Ratio of Krebs Biochemicals & Industries Ltd?

The Current PE Ratio of Krebs Biochemicals & Industries Ltd is 0.0 as on 12 Oct 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Oct 2024.

What was the PE Ratio of Krebs Biochemicals & Industries Ltd last year?

The PE Ratio of Krebs Biochemicals & Industries Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Krebs Biochemicals & Industries Ltd indicate about its stock?

The PE Ratio of Krebs Biochemicals & Industries Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Krebs Biochemicals & Industries Ltd.

What is the PE Ratio Growth of Krebs Biochemicals & Industries Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Krebs Biochemicals & Industries Ltd grew by -% whereas, the EPS ratio grew by -11.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*